Breaking News on Global Meat Trading and Processing

Headlines > Products

Read more breaking news


News in brief

Animal pharmaceutical producer gets US regulatory approval

Post a comment
Oscar Rousseau

By Oscar Rousseau+

Last updated on 25-Jul-2017 at 13:19 GMT2017-07-25T13:19:54Z

ECO's veterinary drug has seen strong sales growth this year
ECO's veterinary drug has seen strong sales growth this year

Veterinary drug producer ECO Animal Health (ECO) has secured a second approval from the US to sell its flagship antibiotic Aivlosin, used to treat a host of swine diseases.

The UK-based firm has pushed to secure regulatory authorisation to market its antibiotics in the US after breaking into the market back in 2012. And the Centre for Veterinary Medicine division of the US Food and Drug Administration (FDA) has approved the use of the drug to treat respiratory diseases in pigs.

Peter Lawrence, chairman of ECO, said the business was “extremely pleased” to secure the second marketing authorisation for Aivlosin in the US.
The swine respiratory disease segment is a key one and this latest approval demonstrates ECO’s continued progress to becoming a major force in the international market for veterinary pharmaceutical products.

The product will be sold via Pharmgate Animal Health, a sales and marketing joint venture ECO formed in 2010 with Pharmgate, a US subsidiary of Chinese veterinary drug producer Jinhe Biotechnology Co.

Last month, ECO posted $17.5m in first-quarter pre-tax profi t, as global pressure to curb antibiotic resistance and stamp up growth promoters boosted demand for the company’s Aivlosin antibiotic – a prescription-only drug used to treat respiratory and enteric diseases in both pigs and poultry.

Post a comment

Comment title *
Your comment *
Your name *
Your email *

We will not publish your email on the site

I agree to Terms and Conditions

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Related products

Related suppliers